Condition
Cisplatin Ototoxicity
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 4 (1)
Trial Status
Completed2
Not Yet Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06929468Not Yet Recruiting
Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer
NCT06297369Phase 2Recruiting
Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients
NCT02099786Not ApplicableCompletedPrimary
Randomized Trial Comparison of Ototoxicity Monitoring Programs
NCT01372904Phase 4CompletedPrimary
Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone Treatment
Showing all 4 trials